Occurrence of low blood glucose concentrations during the afternoon in Type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring
- 1 September 1991
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 34 (9), 662-667
- https://doi.org/10.1007/bf00400996
Abstract
The European NIDDM Policy Group states that the lowest target for good control of Type 2 (non-insulin-dependent) diabetic patients is a blood glucose level 4.4 mmol/l, both fasting and postprandially. The aim of this study is to evaluate the occurrence and temporal distribution of values under this target in the clinical records of 463 Type 2 diabetic patients, treated by diet or diet and oral hypoglycaemic agents, monitored for at least 2 years. The protocol includes blood glucose measurements after overnight fasting (08.00 hours), 120–150 min after breakfast (11.00 hours) and 120 and 240 min after lunch (14.00 and 16.00 hours). At least one blood glucose concentration of less than 4.4 mmol/l was presented by 42% of the patients. The only difference between patients showing and not showing glycaemic levels under this target was the higher percentage on oral hypoglycaemic agents in the first group (68.4% vs 56.9%, p=0.016). We considered 299 blood glucose profiles containing at least one value of less than 4.4 mmol/l, observing that a) 46.9% of profiles from patients treated by diet alone and 68.7% of profiles from patients treated both by diet and oral hypoglycaemic agents presented the lowest blood glucose concentration at 16.00 hours (p=0.002). b) No correlation existed between fasting blood glucose and values at 16.00 hours in profiles from diet-treated patients, whereas a negative correlation was present in patients on diet and oral hypoglycaemic agents, indicating that an excess of oral agents, administered to correct fasting hyperglycaemia. was the cause of the low glycaemic values in the afternoon. c) 37.9% of profiles on a diet and 83.3% of profiles on diet and oral agents showed fasting glucose concentrations >6.7 mmol/l, the upper limit of good control according to the European NIDDM Policy Group. This indicates that fasting hyperglycaemia does not exclude the occurrence of low glucose values throughout the day and that it is necessary to monitor blood glucose profiles.Keywords
This publication has 18 references indexed in Scilit:
- Symptomatic Hypoglycemia in NIDDM Patients Treated With Oral Hypoglycemic AgentsDiabetes Care, 1989
- Three new glucose reflectance meters: Diascan, Glucometer II, and Reflolux IIDiabetes Research and Clinical Practice, 1989
- Optimizing Blood Glucose Control in Type 2 Diabetes: an Approach Based on Fasting Blood Glucose MeasurementsDiabetic Medicine, 1988
- Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.Journal of Clinical Investigation, 1988
- Sulphonylureas and hypoglycaemiaBMJ, 1988
- Management of Non‐insulin‐dependent Diabetes Mellitus in Europe: A Concensus ViewDiabetic Medicine, 1988
- DOES HYPOGLYCAEMIA AGGRAVATE THE COMPLICATIONS OF DIABETES?The Lancet, 1985
- Haemodynamic changes in insulin-induced hypoglycaemia in normal manDiabetologia, 1984
- Plasma Levels of Glibenclamide in Diabetic Patients during its Routine Clinical Administration Determined by a Specific RadioimmunoassayHormone and Metabolic Research, 1983
- Behaviour of glibenclamide on repeated administration to diabetic patientsEuropean Journal of Clinical Pharmacology, 1977